In a groundbreaking development for gene therapy, recent clinical trials have demonstrated significant success in restoring hearing in individuals with congenital deafness. This breakthrough marks the first time gene therapy has effectively reversed this condition not only in children but also in teenagers and young adults. With a simple injection, patients reported remarkable improvements in their ability to hear within weeks, providing new hope for those born with genetic auditory impairments.


